BioSpace News Archive

High EPA Levels Associated with Substantial Reductions in Multiple Cardiovascular Endpoints Including Heart Failure and Total Mortality

Sun Life is donating an initial C$1 million to support communities impacted by the COVID-19 pandemic.

Persons with a substance use disorder (SUD) or history of SUD treatment will now have easier access to fully-informed, comprehensive healthcare with passage of the Protecting Jessica Grubb’s Legacy Act, included in the Coronavirus Aid, Relief, and Economic Security (CARES) Act passed by Congress and signed into law by the President on Friday, March 27.

Dr. Eric von Hofe, PhD, Chief Scientific Officer of NuGenerex Immuno-Oncology to Speak on the Race to Develop a SARS-CoV-2 Vaccine Monday March 30, 2020 at 3 PM

RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company’s novel SkinGun™ is now being used to apply regenerative cells in a preclinical study of new gene therapies, underway at King’s College London

MedSign International Corporation, a leading-edge Telehealth company, announces the nationwide launch of Qortex™; the first and only home TV-based Telehealth solution that enables doctors, hospitals, nurses, and home care agencies to deliver virtual medical services to patients confined to their homes, especially during this COVID-19 pandemic

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that James C. Mullen has agreed to serve as an independent senior advisor to the Company. “We are honored to have Jim as an advisor to Aren

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, provided an update on its operations and actions to address the COVID-19 pandemic.

ValGenesis, Inc. announced that a global biotechnology/chemical and pharmaceutical giant based in Europe has chosen ValGenesis’s cloud-based Validation Lifecycle Management System, to digitalize plant qualification and validation processes across multiple sites.

Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotech company, announced today the appointment of Kristin Keller to the newly created position of Chief Commercial Officer. Kristin will be focused on driving the global